Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts

Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Latest Articles

  • Open Access
    Erratum to Flotillin1 promotes EMT of human small cell lung cancer via TGF-β signaling pathway
    Lianmei Zhao, Jie Li, Yueping Liu, Wei Zhou, Yanan Shan, Xinyi Fan, Xinliang Zhou, Baoen Shan, Yongmei Song and Qimin Zhan
    Cancer Biology & Medicine October 2026, 20260738; DOI: https://doi.org/10.20892/j.issn.2095-3941.2026.0738
  • Open Access
    Efbemalenograstim alfa as prophylaxis for chemotherapy-induced neutropenia in patients with non–small-cell lung cancer: a randomized, multicenter, phase II trial
    Mengjie Li, Caixia Liu, Fengming Ran, Haitao Lan, Jun Ge, Zheng Zhao, Chuangzhou Rao, Wei Zheng, Xiaoyong Tang, Tianhui Gao, Yong Mao, Wei Cui, Zhengguo Li and Dingzhi Huang
    Cancer Biology & Medicine September 2026, 20260311; DOI: https://doi.org/10.20892/j.issn.2095-3941.2026.0311
  • Open Access
    A bispecific EGFR × HER3 antibody–drug conjugate for later-line recurrent or metastatic nasopharyngeal carcinoma: insights from BL-B01D1-303
    Huaqiang Zhou, Jiayi Shen, Jiaqing Liu, Li Zhang and Yunpeng Yang
    Cancer Biology & Medicine September 2026, 20260336; DOI: https://doi.org/10.20892/j.issn.2095-3941.2026.0336
  • Open Access
    Unravelling the role of PANoptosis in diseases: from emerging molecular mechanisms-to-therapeutic implications
    Yi Zhu, Shengming Ou, Xuer Ye, Juncheng Li, Xiaoya Nie, Hongwei Shao, Rongxin Zhang and Jinrong Zhu
    Cancer Biology & Medicine September 2026, 23 (9) 1230-1249; DOI: https://doi.org/10.20892/j.issn.2095-3941.2026.0012
  • Open Access
    Mitochondrial uncoupling inhibits serine catabolism via FTO activation in metastatic breast cancer
    Xin Jin, Albert M. Li, Man Zhao, Haowen Jiang, Yiren Xiao, Michaela Yip, Stavros Melemenidis, Scott Jackson, Yanan Yang, Cathyrin Simmermaker, Meng-Ning Zhou, Subarna Sinha, Daniel J. Cuthbertson, Erinn B. Rankin and Jiangbin Ye
    Cancer Biology & Medicine September 2026, 23 (9) 1303-1319; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0444
  • Open Access
    Circadian-driven transcriptional programs govern metastatic progression
    Jie Wang, Hao Pan, Xuan Wang, Yuru Ren, Yiwen Huang, Yizhou Liu, Hejin Lai, Zhimin Fei, Ning Pu and Yu Wang
    Cancer Biology & Medicine September 2026, 23 (9) 1213-1229; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0491
View more latest articles

Cover Story

Current issue

Cancer Biology & Medicine: 23 (9)
Cancer Biology & Medicine
Vol. 23, Issue 9
15 Sep 2026
  • Table of Contents
  • Index by author

Submit

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives
Back to top

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire